193.00
-10.32
(-5.08%)
At close: 4:45:36 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 24 | 18 | 27 | 27 |
| Avg. Estimate | 3.25B | 3.03B | 12.06B | 13.13B |
| Low Estimate | 3.21B | 3.01B | 12.01B | 12.79B |
| High Estimate | 3.33B | 3.08B | 12.14B | 13.48B |
| Year Ago Sales | 2.96B | 2.76B | 11.39B | 12.06B |
| Sales Growth (year/est) | 9.92% | 9.98% | 5.90% | 8.88% |
EPS Trend
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0I77.L | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 3/24/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/21/2025 |
| Maintains | Citigroup: Buy to Buy | 3/21/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/21/2025 |
| Maintains | Keybanc: Overweight to Overweight | 3/21/2025 |
| Maintains | UBS: Buy to Buy | 3/21/2025 |